Previous 10 | Next 10 |
Eastman Kodak (NYSE: KODK ) -39% after drug loan pause . More news on: Eastman Kodak Company, Neovasc Inc., Kazia Therapeutics Limited, Stocks on the move, , Read more ...
Recro Pharma (NASDAQ: REPH ) : Q2 GAAP EPS of -$0.25 misses by $0.09 . Revenue of $15.5M (-50.4% Y/Y) misses by $3.38M . Press Release More news on: Recro Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,
Launches Clinical Trial Materials Business and Secures New Customers Company to Host Conference Call Today at 8:00 a.m. ET MALVERN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrate...
Original Post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
MALVERN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, t...
Company Owns and Operates Over 120,000 Square Feet of U.S. cGMP and DEA-Licensed Contract Development and Manufacturing Facilities Focused on Creating Oral, Solid Dose Drug Products Long, Proven Track Record of Successful Commercial Drug Product Manufacturing, Serving Both Large Pharm...
BOSTON, May 11, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a national securities litigation firm, announces that it has launched an investigation into potential securities fraud by Recro Pharma Inc. (NASDAQ: REPH) and certain of its officers. Investors who have...
Gainers: Cellect Biotechnology (NASDAQ: APOP ) +77% . More news on: Cellect Biotechnology Ltd., MyoKardia, Inc., Remark Holdings, Inc., Stocks on the move, , Read more ...
Recro Pharma, Inc. (REPH) Q1 2020 Results Earnings Conference Call May 11, 2020, 08:00 AM ET Company Participants Claudia Styslinger - IR Gerri Henwood - President & CEO Ryan Lake - CFO Conference Call Participants Leland Gershell - Oppenheimer Esther Hong - Janney Mo...
Recro Pharma ( REPH -40.6% ) Q1 results : More news on: Recro Pharma, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...